CNS Pharmaceuticals, Inc. (CNSP) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$15.85M | -6.7% |
| 2024 | -$14.86M | +21.2% |
| 2023 | -$18.85M | -23.4% |
| 2022 | -$15.27M | -5.4% |
| 2021 | -$14.50M | -53.3% |
| 2020 | -$9.46M | -143.9% |
| 2019 | -$3.88M | +47.5% |
| 2018 | -$7.39M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$15.85M | -6.7% |
| 2024 | -$14.86M | +21.2% |
| 2023 | -$18.85M | -23.4% |
| 2022 | -$15.27M | -5.4% |
| 2021 | -$14.50M | -53.3% |
| 2020 | -$9.46M | -143.9% |
| 2019 | -$3.88M | +47.5% |
| 2018 | -$7.39M | — |